Precision Oncology Network Syapse's global provider network and past oncology collaborations position it to expand precision medicine programs within community cancer centers and health systems. Target pharma and payer customers seeking real world evidence to inform approvals, label expansions, and optimized care pathways.

Acquisition Synergy The January 2025 acquisition by N Power Medicine creates a pathway to integrate Syapse platform capabilities with clinical trial process reinvention, enabling real world data capture, patient recruitment, and trial optimization across sites.

Pharma Partnerships Past and potential partnerships with industry leaders such as Amgen and Main Line Health demonstrate appetite for deep networked real world evidence solutions. Focus outreach on oncology drug development programs and cohort studies.

Tech Integration Technology stack already includes Salesforce, Google Cloud, NoSQL and other cloud tools, suggesting readiness for integration with customer systems. Propose value through data interoperability, analytics, and custom dashboards tailored to cancer care programs.

Mid Market Growth With a lean team and mid market footprint, Syapse offers an opportunity to accelerate growth by expanding to mid size health systems and community hospitals seeking scalable real world evidence solutions, payer alignment, and care pathway insights.